Just 8% of patients who tested negative for BSP went on to develop BM, compared to 22% of patients who tested positive for BSP developed BM, according to a retrospective analysis of BSP values in pathological tissue of breast cancer from 454 individuals [77]. Here, IBSP is linked to breast carcinoma.